Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS (unaudited)

v2.4.0.8
CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS (unaudited) (USD $)
In Thousands, except Per Share data, unless otherwise specified
3 Months Ended
Mar. 31, 2014
Mar. 31, 2013
Revenues:    
License and collaborative fees $ 964 $ 399
Contract and other 2,446 9,054
Total revenues 3,410 9,453
Operating expenses:    
Research and development 21,546 16,636
Selling, general and administrative 5,254 4,124
Restructuring 84 17
Total operating expenses 26,884 20,777
Loss from operations (23,474) (11,324)
Other income (expense):    
Interest expense (1,125) (1,172)
Other (expense) income (90) 449
Revaluation of contingent warrant liabilities 20,002 (12,840)
Net loss (4,687) (24,887)
Basic net loss per share of common stock (in dollars per shares) $ (0.04) $ (0.30)
Diluted net loss per share of common stock - restated for the three months ended March 31, 2014 (in dollars per share) $ (0.21) $ (0.30)
Shares used in computing basic net loss per share of common stock (in shares) 106,158 82,595
Shares used in computing diluted net loss per share of common stock - restated for the three months ended March 31, 2014 (in shares) 115,524 82,595
Other comprehensive loss:    
Net loss (4,687) (24,887)
Net unrealized gains on available-for-sale securities 7 3
Comprehensive loss $ (4,680) $ (24,884)